<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Inside BCI</title><description>Brain-Computer Interface industry news, research breakthroughs, and market analysis.</description><link>https://insidebci.com/</link><language>en-us</language><item><title>Synchron co-founder Nicholas Opie joins Control Bionics board as Non-Executive Director</title><link>https://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/</link><guid isPermaLink="true">https://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/</guid><description>Opie joins ASX-listed Australian assistive-tech company Control Bionics as Non-Executive Director and strategic advisor, with 1.25 million options vesting over four years pending shareholder approval at the 2026 AGM.</description><pubDate>Thu, 14 May 2026 00:00:00 GMT</pubDate><category>market</category><category>market</category><category>executive-movement</category><category>nicholas-opie</category><category>control-bionics</category><category>synchron</category><category>ultra-bionics</category><category>australia</category><category>assistive-technology</category><category>board-appointment</category></item><item><title>Real-time brain-controlled selective hearing isolates one voice in a crowd in first human study</title><link>https://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/</link><guid isPermaLink="true">https://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/</guid><description>Columbia&apos;s Zuckerman Institute and collaborators at UCSF, NYU and Northwell Health published the first real-time human-study evidence that an auditory attention decoding BCI can isolate a single speaker in a multi-talker environment.</description><pubDate>Tue, 12 May 2026 00:00:00 GMT</pubDate><category>research</category><category>research</category><category>auditory-attention-decoding</category><category>aad</category><category>brain-controlled-hearing</category><category>columbia-zuckerman-institute</category><category>mesgarani</category><category>edward-chang</category><category>consumer-audio</category><category>intracranial-eeg</category></item><item><title>Thailand emerges as a BCI commercial corridor with C.P. Group connecting US and Chinese capability</title><link>https://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/</link><guid isPermaLink="true">https://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/</guid><description>C.P. Group Innovation led Axoft&apos;s $55 million Series A on 29 April 2026. One day earlier, C.P. Group subsidiary True Corporation announced a clinical pilot partnership with Shanghai-based OYMotion. The Thai conglomerate is now operating across both Western and Chinese BCI capability through different mechanisms.</description><pubDate>Sun, 10 May 2026 00:00:00 GMT</pubDate><category>market</category><category>market</category><category>thailand</category><category>china-bci</category><category>cp-group</category><category>cp-group-innovation</category><category>true-corporation</category><category>oymotion</category><category>axoft</category><category>southeast-asia</category><category>industrial-builder</category><category>neuro-rehabilitation</category></item><item><title>Inspire takes the first quantified WISeR hit as Medicare bifurcates its neuromodulation posture</title><link>https://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/</guid><description>Inspire&apos;s Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.</description><pubDate>Fri, 08 May 2026 00:00:00 GMT</pubDate><category>policy</category><category>regulation</category><category>cms</category><category>wiser</category><category>medicare</category><category>neuromodulation</category><category>inspire-medical</category><category>neuropace</category><category>reimbursement</category><category>bci-read-through</category></item><item><title>Order 818 takes effect: BCI joins gene and cell therapy on China&apos;s parallel commercial track</title><link>https://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/</guid><description>The State Council&apos;s biomedical-new-technologies regulation took effect 1 May 2026, letting Chinese hospitals charge for BCI commercially after a translation approval. Foreign-invested enterprises remain locked out.</description><pubDate>Fri, 08 May 2026 00:00:00 GMT</pubDate><category>policy</category><category>regulation</category><category>china</category><category>order-818</category><category>nmpa</category><category>nhc</category><category>industrial-builder</category><category>neuracle</category><category>commercial-pathway</category></item><item><title>The sovereign and tech-billionaire rush to access the brain is accelerating</title><link>https://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/</link><guid isPermaLink="true">https://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/</guid><description>Oman Investment Authority&apos;s Neuralink position is the latest entry in a sovereign-capital and tech-billionaire cohort racing into brain-computer interfaces.</description><pubDate>Fri, 08 May 2026 00:00:00 GMT</pubDate><category>opinion</category><category>opinion</category><category>sovereign-capital</category><category>geopolitics</category><category>bci-investment</category><category>tech-giants</category><category>neuralink</category><category>synchron</category><category>paradromics</category><category>inbrain</category><category>synaptrix-labs</category><category>merge-labs</category></item><item><title>Vermont H.814 clears Senate, neural rights statute awaits Governor Scott</title><link>https://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/</guid><description>The Senate passed H.814 in concurrence with the House on 6 May. What now sits with Governor Scott is a 6-page recognition statute, with the enforcement layer stripped in committee.</description><pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate><category>policy</category><category>regulation</category><category>neurorights</category><category>vermont</category><category>us-state-patchwork</category><category>neural-data-privacy</category><category>yuste</category></item><item><title>EU AI Act enforcement for BCI medical devices delayed to August 2028 in Council-Parliament deal</title><link>https://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/</guid><description>The provisional agreement reached on 7 May 2026 pushes high-risk AI obligations by 16 to 24 months, including the rules that capture Class IIb and Class III medical-device BCIs.</description><pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate><category>policy</category><category>regulation</category><category>eu-ai-act</category><category>european-union</category><category>medical-device</category><category>compliance</category><category>horizontal-regulator</category><category>digital-omnibus</category><category>mdr</category></item><item><title>Bioelectronic medicine reaches commercial inflection across four companies in two weeks</title><link>https://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/</link><guid isPermaLink="true">https://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/</guid><description>Spark Biomedical&apos;s CEO appointment on May 4 caps a fortnight of substantive bioelectronic-medicine milestones: SetPoint Medical&apos;s first multiple sclerosis pilot enrolment on April 30, ResMed&apos;s $340 million acquisition of Noctrix Health on the same day, and Nervonik&apos;s $52.5 million Series B on April 27. Together the four data points map onto a single maturation arc — growth-stage capital, late-stage trial expansion, commercial scaling, incumbent acquisition — and signal that the category is moving past early-clinical research into the operational layer where all four of those events run in parallel.</description><pubDate>Tue, 05 May 2026 00:00:00 GMT</pubDate><category>market</category><category>bioelectronic-medicine</category><category>spark-biomedical</category><category>setpoint-medical</category><category>nervonik</category><category>resmed</category><category>noctrix</category><category>anja-krammer</category><category>vagus-nerve</category><category>peripheral-nerve-stim</category><category>commercial-inflection</category><category>m-and-a</category></item><item><title>Former Harvard chemistry chair Charles Lieber leads state-funded Shenzhen BCI lab i-BRAIN</title><link>https://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/</guid><description>Reuters reported on April 30 that Charles Lieber, the former chair of Harvard&apos;s chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft&apos;s $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.</description><pubDate>Thu, 30 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>lieber</category><category>harvard</category><category>i-brain</category><category>shenzhen</category><category>china</category><category>smart</category><category>mesh-electronics</category><category>nanowire</category><category>talent-flow</category><category>china-initiative</category><category>state-funded</category><category>five-year-plan</category></item><item><title>UChicago Medicine joins Precision Neuroscience&apos;s clinical research network with Layer 7 sensorimotor partnership</title><link>https://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/</guid><description>Precision Neuroscience and UChicago Medicine announced on April 30 the launch of a clinical research partnership focused on AI-driven sensorimotor function and neuroprosthetics. The collaboration uses Precision&apos;s Layer 7 Cortical Interface, the FDA 510(k)-cleared high-density microelectrode array, and is the second material Precision institutional move of 2026, following the company&apos;s January integration with Medtronic&apos;s StealthStation surgical navigation system.</description><pubDate>Thu, 30 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>precision-neuroscience</category><category>layer-7</category><category>uchicago-medicine</category><category>peter-warnke</category><category>sensorimotor-decoding</category><category>neuroprosthetics</category><category>medtronic</category><category>stealthstation</category><category>academic-medical-centre</category></item><item><title>Axoft draws C.P. Group lead in $55M Series A as US BCI company runs first acute implant in Shanghai</title><link>https://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/</guid><description>Cambridge, Massachusetts implantable BCI company Axoft closed a $55M oversubscribed Series A on April 29, led by Thai conglomerate Charoen Pokphand&apos;s strategic arm C.P. Group Innovation with Chinese co-investors Hillhouse and Gaorong, alongside US participants Alumni Ventures and Stanford. The same announcement disclosed Axoft&apos;s first acute intraoperative test of its Fleuron polymer probe in a Shanghai patient — the first publicly confirmed clinical use of a US BCI material in China, with more Chinese trials planned this year.</description><pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>axoft</category><category>fleuron</category><category>series-a</category><category>cp-group</category><category>hillhouse</category><category>gaorong</category><category>stanford</category><category>alumni-ventures</category><category>shanghai</category><category>china</category><category>acute-recording</category><category>implantable-bci</category><category>paul-le-floch</category></item><item><title>Neurable launches OEM licensing programme, opening its EEG-decoder stack to consumer hardware makers</title><link>https://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/</guid><description>Neurable announced on April 28 that it has formally opened its consumer-EEG technology to OEM licensing, allowing third-party hardware makers to integrate the company&apos;s brain-signal-processing stack into their own products. Named integration partners include HP Inc.&apos;s HyperX, MeSpace, iMotions, and the United States Air Force Research Laboratory. The shift recasts Neurable from a hardware company building its own consumer products into a platform layer for the broader consumer-electronics stack.</description><pubDate>Tue, 28 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>neurable</category><category>oem-licensing</category><category>consumer-bci</category><category>eeg</category><category>hyperx</category><category>hp</category><category>imotions</category><category>afrl</category><category>ramses-alcaide</category><category>neurable-ai</category><category>platform-strategy</category></item><item><title>Motif Neurotech&apos;s DOT wins FDA IDE for first clinical trial in treatment-resistant depression</title><link>https://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/</guid><description>The FDA has approved Motif Neurotech&apos;s investigational device exemption to begin a first-in-patient clinical trial of DOT, a millimeter-scale epidurally implanted wirelessly powered brain stimulator that targets the prefrontal cortex. The Rice University spinout, backed by former Neuralink president Max Hodak among others, becomes one of the first companies to attempt an implantable depression therapy at the size and patient-acceptance profile that has eluded every prior DBS-for-depression programme.</description><pubDate>Mon, 27 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>motif-neurotech</category><category>dot</category><category>fda</category><category>ide</category><category>depression</category><category>treatment-resistant-depression</category><category>epidural</category><category>brain-stimulator</category><category>max-hodak</category><category>rice-university</category><category>magnetoelectric</category><category>implantable</category></item><item><title>Orchestra BioMed and Medtronic move pacemaker-delivered hypertension therapy toward pivotal readout</title><link>https://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/</guid><description>MODERATO II data presented at Heart Rhythm 2026 shows AVIM Therapy — bioelectronic blood pressure control delivered through a standard dual-chamber pacemaker — produced an 8.1 mmHg net reduction in 24-hour ambulatory systolic BP at six months, with the Medtronic-partnered BACKBEAT pivotal trial now actively enrolling under an FDA-amended protocol.</description><pubDate>Mon, 27 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>orchestra-biomed</category><category>medtronic</category><category>avim</category><category>bioelectronic</category><category>hypertension</category><category>pacemaker</category><category>hrs-2026</category><category>fda-breakthrough</category><category>backbeat</category><category>moderato-ii</category></item><item><title>China issues guided pricing for invasive BCI procedures as provinces begin reimbursement roll-out</title><link>https://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/</guid><description>China&apos;s National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.</description><pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>china</category><category>nhsa</category><category>reimbursement</category><category>pricing</category><category>neuroxess</category><category>stairmed</category><category>neuracle</category><category>market-access</category><category>regulatory</category><category>cms</category></item><item><title>FDA signals long-horizon regulatory commitment as CorTec joins Total Product Life Cycle Advisory Program</title><link>https://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/</guid><description>Two weeks after securing Breakthrough Device Designation for stroke rehabilitation, CorTec has been accepted into the FDA&apos;s TAP — a dedicated advisory track that pairs the German neurotech company with an agency liaison and early engagement with CMS, signalling an unusually long regulatory horizon for an implanted brain-computer interface.</description><pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>cortec</category><category>fda</category><category>tap</category><category>brain-interchange</category><category>closed-loop</category><category>stroke</category><category>regulatory</category><category>cms</category><category>reimbursement</category></item><item><title>Macaque BCI Navigates Virtual Forest With a Single Fixed Decoder Across Task Switches</title><link>https://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/</guid><description>A KU Leuven team led by Peter Janssen trained three rhesus macaques to pilot avatars through virtual environments using implanted multi-array BCIs, with premotor cortex outperforming primary motor cortex and a single fixed decoder generalising across perspectives, avatars, and dynamic targets.</description><pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>KU-Leuven</category><category>Janssen</category><category>macaque</category><category>premotor-cortex</category><category>motor-decoding</category><category>virtual-reality</category><category>brain-computer-interface</category><category>Science-Advances</category><category>ALS</category><category>Parkinsons</category></item><item><title>Maharbiz Launches Epia Neuro, a Stroke-Focused BCI Built for Lifelong Assistive Use</title><link>https://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/</guid><description>Michel Maharbiz departed iota Biosciences on 1 April and has emerged with a San Francisco BCI startup targeting post-stroke upper-limb rehabilitation, with a 64-channel epidural array, motorised glove, first-in-human at Lenox Hill later this year, and an FDA submission targeted for February 2027.</description><pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>Epia-Neuro</category><category>Maharbiz</category><category>Mandelbaum</category><category>stroke</category><category>brain-computer-interface</category><category>epidural-BCI</category><category>Lenox-Hill</category><category>iota-Biosciences</category><category>Astellas</category></item><item><title>Northwestern Prints Artificial Neurons That Fire Action Potentials Into Live Brain Tissue</title><link>https://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/</guid><description>A Mark Hersam-led team at Northwestern has demonstrated aerosol-jet-printed neuromorphic devices that generate biologically realistic voltage spikes and trigger responses in mouse cerebellum slices, a first for printed electronics and a potential route to lower-cost, flexible neural interfaces.</description><pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>Northwestern</category><category>Hersam</category><category>printed-electronics</category><category>neuromorphic</category><category>MoS2</category><category>graphene</category><category>brain-computer-interface</category><category>neuroprosthetics</category><category>Nature-Nanotechnology</category></item><item><title>INBRAIN Completes Enrolment in World&apos;s First-in-Human Graphene Brain-Computer Interface Study</title><link>https://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/</guid><description>The Barcelona neurotechnology enrolled ten patients and implanted eight during brain tumour resection at Salford Royal Hospital, completing the first human cohort for any graphene-based neural interface. Full results due later in 2026.</description><pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>INBRAIN-Neuroelectronics</category><category>graphene-BCI</category><category>brain-computer-interface</category><category>Salford-Royal</category><category>University-of-Manchester</category><category>Kostarelos</category><category>Parkinsons-disease</category><category>BCI-Tx-platform</category></item><item><title>ONWARD Medical Raises €40.6m to Scale ARC Therapy Rollout and Fund Implantable Pipeline</title><link>https://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/</guid><description>The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.</description><pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>ONWARD-Medical</category><category>ARC-therapy</category><category>spinal-cord-injury</category><category>EQT-Life-Sciences</category><category>capital-raise</category><category>Euronext</category><category>neurotech-commercialization</category><category>brain-computer-interface</category></item><item><title>ANEUVO&apos;s spinal stimulator clears the FDA</title><link>https://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/</guid><description>The ExaStim system — a transcutaneous spinal cord stimulator for people with chronic spinal cord injury — has received FDA 510(k) clearance, making it the first device of its kind cleared for both clinical and home use in the United States.</description><pubDate>Thu, 16 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>ANEUVO</category><category>FDA</category><category>spinal cord stimulation</category><category>ExaStim</category><category>spinal cord injury</category><category>neuromodulation</category><category>510(k)</category></item><item><title>Bidirectional brain-computer interface restores sensation during brain-controlled walking</title><link>https://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/</guid><description>A UC Irvine-led team has demonstrated the first brain-computer interface that simultaneously controls a walking exoskeleton through decoded brain signals and feeds artificial leg sensation back to the user&apos;s sensory cortex — closing the loop on locomotion for the first time.</description><pubDate>Thu, 16 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>UC Irvine</category><category>Caltech</category><category>USC</category><category>bidirectional BCI</category><category>exoskeleton</category><category>sensory feedback</category><category>electrocorticography</category><category>Brain Stimulation</category></item><item><title>Sabi emerges from stealth with a thought-to-text beanie and Khosla backing</title><link>https://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/</guid><description>California startup Sabi has exited stealth with a non-invasive EEG beanie packing up to 100,000 miniature sensors, a brain foundation model trained on 100,000 hours of neural data, and a plan to ship a consumer thought-to-text device by the end of 2026. Khosla Ventures leads.</description><pubDate>Thu, 16 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>Sabi</category><category>EEG</category><category>consumer BCI</category><category>wearable</category><category>Khosla Ventures</category><category>brain foundation model</category><category>thought-to-text</category></item><item><title>Neuroethics 2026 opens at Stanford as the field meets its first commercial moment</title><link>https://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/</guid><description>The International Neuroethics Society convenes across Stanford, Lucca and Stellenbosch as the BCI sector absorbs $960 million in Q1, a Chinese reimbursement benchmark of US$900 per implant, and 20 Neuralink patients — and the governance window is narrowing.</description><pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate><category>policy</category><category>neuroethics</category><category>INS</category><category>Stanford</category><category>neurorights</category><category>cognitive liberty</category><category>neural data</category><category>governance</category><category>BCI Pioneers Coalition</category></item><item><title>Phantom Neuro gets green light for first human trial of its subcutaneous prosthetic sensor</title><link>https://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/</guid><description>The Melbourne-based startup has received FDA approval to begin a first-in-human study of Phantom X, an implanted sensor array that reads neuromuscular signals from a residual limb without entering the nervous system — aiming to give amputees more natural prosthetic control.</description><pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>Phantom Neuro</category><category>prosthetics</category><category>CYBORG</category><category>first-in-human</category><category>subcutaneous sensor</category><category>amputation</category><category>FDA</category><category>Ottobock</category><category>Blackrock Neurotech</category></item><item><title>China livestreams a brain implant: Beinao-1 goes live</title><link>https://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/</guid><description>Hundreds of specialists watched Beijing Tiantan Hospital implant Beinao-1, China&apos;s 128-channel semi-invasive brain-computer interface, in a young man paralysed in a scooter accident — part of a clinical ramp that is closing on Neuralink&apos;s implant count at roughly 1% of its price.</description><pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>Beinao-1</category><category>China</category><category>Beijing Tiantan Hospital</category><category>CIBR</category><category>NeuCyber NeuroTech</category><category>semi-invasive BCI</category><category>clinical trials</category></item><item><title>Purdue grows brain electrodes inside the brains of living mice</title><link>https://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/</guid><description>A Purdue team reports in Science that a liquid monomer injected into the motor cortex self-assembles into a conductive electrode mesh — catalysed by the iron in blood — and can then modulate neural activity with external near-infrared light.</description><pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>Purdue</category><category>Jianguo Mei</category><category>n-PBDF</category><category>injectable electrodes</category><category>conductive polymers</category><category>Science</category><category>bioelectronics</category></item><item><title>China&apos;s First BCI Unicorn Pivots Prosthetics Expertise Into Humanoid Robot Hands</title><link>https://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/</guid><description>BrainCo&apos;s new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.</description><pubDate>Mon, 13 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>BrainCo</category><category>robotics</category><category>prosthetics</category><category>dexterous hands</category><category>China</category><category>humanoid robots</category></item><item><title>Neural Dust Co-Inventor Headlines Bioelectronic Medicine Forum as Neurotech Investment Accelerates</title><link>https://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/</guid><description>Michel Maharbiz of iota Biosciences will keynote the ninth annual Bioelectronic Medicine Forum in New York on April 14, with panels on reimbursement and venture capital following a record Q1 for BCI funding.</description><pubDate>Sat, 11 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>bioelectronic-medicine-forum</category><category>michel-maharbiz</category><category>iota-biosciences</category><category>neural-dust</category><category>venture-capital</category><category>neurotech-reports</category><category>reimbursement</category></item><item><title>DARPA Launches O-CIRCUIT to Build Living Neural Computers for the Battlefield</title><link>https://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/</guid><description>A new 42-month programme will fund teams to build biological processing units from neural organoids, benchmarked against video games and drone navigation, at energy budgets rivalling a fruit fly&apos;s brain.</description><pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>darpa</category><category>o-circuit</category><category>organoids</category><category>biological-computing</category><category>bpu</category><category>edge-ai</category><category>olfactory</category><category>chemotaxis</category><category>defence</category></item><item><title>Neuralink Reaches Twenty-Implant Milestone as Surgical Robot Relocates to the UAE</title><link>https://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/</guid><description>With seven UK patients implanted under the GB-PRIME study and a total of twenty worldwide, Neuralink&apos;s R1 surgical robot has moved to Cleveland Clinic Abu Dhabi for the next cohort under the UAE-PRIME trial.</description><pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>neuralink</category><category>gb-prime</category><category>uae-prime</category><category>uclh</category><category>cleveland-clinic</category><category>r1-robot</category><category>n1-implant</category><category>quadriplegia</category></item><item><title>Colorado Performs Its First Brain-Computer Interface Surgery, Targeting Higher Cognitive Regions</title><link>https://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/</guid><description>Neurosurgeon Daniel Kramer implants a BCI in a quadriplegic patient at UCHealth University of Colorado Hospital, with electrodes placed in higher-level brain areas rather than motor cortex alone.</description><pubDate>Thu, 09 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>cu-anschutz</category><category>uchealth</category><category>colorado</category><category>utah-array</category><category>cognitive-bci</category><category>sensory-stimulation</category><category>daniel-kramer</category><category>quadriplegia</category></item><item><title>CorTec Wins FDA Breakthrough Designation for Stroke Rehab BCI, a First for the Indication</title><link>https://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/</guid><description>The German neurotech company becomes the first to receive FDA Breakthrough Device Designation for a brain-computer interface targeting motor recovery after stroke, with its closed-loop Brain Interchange system showing meaningful recovery in a Harborview Medical Center trial.</description><pubDate>Thu, 09 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>cortec</category><category>fda</category><category>breakthrough-device</category><category>stroke</category><category>brain-interchange</category><category>closed-loop</category><category>harborview</category><category>neurostimulation</category></item><item><title>Precision Neuroscience&apos;s Layer 7 Decodes Speech and Movement in First Peer-Reviewed Intraoperative Study</title><link>https://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/</guid><description>A Johns Hopkins team reports 77.5% speech classification and 78–84% motor decoding accuracy using Precision&apos;s 1,024-channel thin-film cortical array during awake brain surgery in four patients.</description><pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>precision-neuroscience</category><category>layer-7</category><category>electrocorticography</category><category>speech-decoding</category><category>motor-decoding</category><category>johns-hopkins</category><category>medtronic</category></item><item><title>GAO Names Neural Implants Among Three Emerging Priorities for Congress</title><link>https://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/</guid><description>A Government Accountability Office report warns that the FDA has no framework for augmentation uses of brain-computer interfaces, even as military and commercial applications advance.</description><pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate><category>policy</category><category>gao</category><category>fda</category><category>policy</category><category>augmentation</category><category>regulation</category></item><item><title>Living Rat Neurons Learn to Generate Complex Signals in Real-Time Reservoir Computing First</title><link>https://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/</guid><description>Tohoku University researchers trained cultured rat cortical neurons to produce sine waves, square waves, and chaotic Lorenz attractors using closed-loop FORCE learning, demonstrating that biological neural networks can serve as computational resources.</description><pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>reservoir-computing</category><category>biocomputing</category><category>tohoku-university</category><category>organoid-intelligence</category><category>neuroprosthetics</category><category>pnas</category></item><item><title>Synchron&apos;s Neural Data Ambitions Earn Fast Company Recognition as BCI Dataset Grows</title><link>https://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/</guid><description>Synchron ranked eighth on Fast Company&apos;s 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.</description><pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>synchron</category><category>neural-data</category><category>chiral</category><category>foundation-model</category><category>fast-company</category></item><item><title>Neuronoff&apos;s Needle-Delivered Electrode Works With Standard Pulse Generators in Chronic Animal Study</title><link>https://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/</link><guid isPermaLink="true">https://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/</guid><description>Cleveland-based Neuronoff showed its Injectrode platform can connect to off-the-shelf implantable pulse generators, opening neuromodulation targets beyond the spine.</description><pubDate>Sun, 05 Apr 2026 00:00:00 GMT</pubDate><category>market</category><category>neuronoff</category><category>injectrode</category><category>neuromodulation</category><category>chronic-pain</category><category>peripheral-nerve-stimulation</category></item><item><title>China Elevates BCI to Government Work Report as Clinical Programmes Expand</title><link>https://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/</guid><description>Brain-computer interfaces appeared in China&apos;s government work report for the first time during the 2026 &apos;two sessions,&apos; placing the technology alongside quantum computing and 6G as a national strategic priority.</description><pubDate>Sat, 04 Apr 2026 00:00:00 GMT</pubDate><category>policy</category><category>China</category><category>government work report</category><category>two sessions</category><category>NPC</category><category>CPPCC</category><category>BCI policy</category><category>Chongqing</category><category>clinical trials</category><category>neuromodulation</category><category>stroke rehabilitation</category></item><item><title>Paralysed Punk Rocker Turns Blackrock Neurotech Implants Into a Musical Instrument</title><link>https://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/</guid><description>Galen Buckwalter, a quadriplegic research psychologist with six Utah arrays in his brain, is using a Caltech-developed interface to generate music directly from neural signals.</description><pubDate>Sat, 04 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>blackrock-neurotech</category><category>caltech</category><category>creative-expression</category><category>utah-array</category><category>brain-computer-interface</category></item><item><title>Personalised TMS Reaches the Hippocampus Without Surgery, Iowa Study Shows</title><link>https://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/</link><guid isPermaLink="true">https://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/</guid><description>University of Iowa researchers have demonstrated for the first time that non-invasive transcranial magnetic stimulation can modulate hippocampal activity when the stimulation site is tailored to each patient&apos;s brain connectivity.</description><pubDate>Sat, 04 Apr 2026 00:00:00 GMT</pubDate><category>research</category><category>TMS</category><category>hippocampus</category><category>non-invasive</category><category>neuromodulation</category><category>University of Iowa</category><category>Nature Communications</category><category>personalised medicine</category><category>Alzheimer&apos;s</category><category>depression</category><category>fMRI</category></item><item><title>Epia Neuro Launches With Read-Write BCI Platform for Stroke Rehabilitation</title><link>https://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/</link><guid isPermaLink="true">https://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/</guid><description>The startup, led by iota Biosciences founder Michel Maharbiz, is developing a minimally invasive brain-computer interface that pairs neural decoding with a motorized grip-assist glove to restore movement after stroke.</description><pubDate>Fri, 03 Apr 2026 00:00:00 GMT</pubDate><category>news</category><category>Epia Neuro</category><category>stroke</category><category>rehabilitation</category><category>BCI</category><category>Michel Maharbiz</category><category>iota Biosciences</category><category>Lenox Hill Hospital</category><category>closed-loop</category></item><item><title>US States Build Patchwork of Neural Data Privacy Laws as BCI Market Accelerates</title><link>https://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/</guid><description>Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.</description><pubDate>Fri, 03 Apr 2026 00:00:00 GMT</pubDate><category>policy</category><category>neural data</category><category>privacy</category><category>legislation</category><category>Connecticut</category><category>California</category><category>Colorado</category><category>Montana</category><category>neurorights</category><category>UNESCO</category><category>BCI</category></item><item><title>BCI Sector Closes Record First Quarter With Over $960 Million Raised</title><link>https://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/</guid><description>At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.</description><pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>funding</category><category>BCI</category><category>investment</category><category>Q1 2026</category><category>analysis</category><category>Merge Labs</category><category>Synchron</category><category>Science Corp</category></item><item><title>Paradromics Begins Recruiting Patients for Connexus Speech-Restoration Trial</title><link>https://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/</guid><description>The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.</description><pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Paradromics</category><category>Connexus</category><category>Connect-One</category><category>clinical trial</category><category>speech restoration</category><category>FDA</category><category>BCI</category></item><item><title>Asilomar Summit Convenes to Build Governance Toolkit for Neurotechnology</title><link>https://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/</guid><description>A four-day invitation-only summit modelled on the landmark 1975 DNA conference brings together neuroethicists, investors, and policymakers to create practical governance tools for the BCI industry.</description><pubDate>Sun, 29 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>policy</category><category>neuroethics</category><category>governance</category><category>Asilomar</category><category>OECD</category><category>IEEE</category><category>UNESCO</category></item><item><title>Merge Labs&apos; $252M Bet on Ultrasound BCI Faces Scientific Scrutiny</title><link>https://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/</guid><description>Sam Altman&apos;s brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.</description><pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>Merge Labs</category><category>BCI</category><category>funding</category><category>OpenAI</category><category>ultrasound</category><category>Sam Altman</category><category>analysis</category></item><item><title>Octane&apos;s Neuro Tech Forum Draws J&amp;J, Medtronic, and Blackrock Neurotech to Newport Beach</title><link>https://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/</guid><description>The second annual forum brought together device makers, investors, and six early-stage startups for two days of panels on BCI, neuromodulation, and digital health.</description><pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>neurotech</category><category>investment</category><category>BCI</category><category>Blackrock Neurotech</category><category>Octane</category><category>medtech</category></item><item><title>UK Funds £1 Million Philosophy of Neurotechnology Research Lab</title><link>https://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/</guid><description>Four philosophers at Glasgow and Oxford will lead a new interdisciplinary lab examining the ethical and epistemological implications of brain-computer interfaces.</description><pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>policy</category><category>ethics</category><category>UK</category><category>neurotechnology</category><category>philosophy</category><category>UKRI</category><category>Glasgow</category><category>Oxford</category></item><item><title>Synchron Returns to Melbourne for First Trial of Next-Generation Stentrode</title><link>https://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/</guid><description>The FOCUS-AU trial will test Synchron&apos;s advanced brain-computer interface in ten MND patients across three Australian hospitals, with surgery beginning in April.</description><pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Synchron</category><category>Stentrode</category><category>Australia</category><category>FOCUS-AU</category><category>MND</category><category>ALS</category><category>clinical trial</category><category>Apple</category></item><item><title>Cambridge Innovation Institute Acquires Neurotech Reports After 25 Years of Independent Publishing</title><link>https://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/</guid><description>CII absorbs the neurotechnology sector&apos;s longest-running trade publication into its venture and innovation division, with founder James Cavuoto and team staying on.</description><pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>Neurotech Reports</category><category>Cambridge Innovation Institute</category><category>acquisition</category><category>neurotech industry</category><category>James Cavuoto</category><category>bioelectronic medicine</category></item><item><title>China&apos;s Beinao-1 Reaches Five Patients With Semi-Invasive Brain Chip</title><link>https://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/</guid><description>Five patients now carry the coin-sized wireless implant that sits on the brain&apos;s protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.</description><pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Beinao-1</category><category>NeuCyber</category><category>China</category><category>semi-invasive</category><category>BCI</category><category>Neuralink</category><category>ALS</category></item><item><title>Nia Therapeutics Wins FDA Breakthrough Designation for AI-Guided Memory Implant</title><link>https://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/</guid><description>The Pennsylvania company&apos;s 60-channel Smart Neurostimulation System is the first device to receive Breakthrough Device Designation for TBI-related memory loss.</description><pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Nia Therapeutics</category><category>FDA</category><category>memory</category><category>TBI</category><category>neurostimulation</category><category>closed-loop</category><category>breakthrough device</category></item><item><title>Cleveland Startup Sells $350 Brain Stimulation Headset Without FDA Clearance While Clinical Trials Continue</title><link>https://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/</guid><description>U: The Mind Company began taking orders for a consumer neuromodulation device on March 18, marketing bold clinical claims that have not appeared in peer-reviewed literature. An FDA submission is planned for 2027.</description><pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>consumer-neurotech</category><category>brain-stimulation</category><category>tRNS</category><category>FDA</category><category>wellness-devices</category><category>regulation</category></item><item><title>Flow Neuroscience Brings First FDA-Approved At-Home Brain Stimulation for Depression to US Market</title><link>https://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/</guid><description>The Swedish company&apos;s FL-100 headset, cleared via the FDA&apos;s most stringent PMA pathway, launches in the US in Q2 2026 after a 174-person Nature Medicine trial. A second device, Neurolief&apos;s ProlivRx, was approved weeks later.</description><pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Flow-Neuroscience</category><category>FDA</category><category>depression</category><category>tDCS</category><category>neuromodulation</category><category>at-home-therapy</category><category>Neurolief</category></item><item><title>Spinal Cord Stimulation Restores Both Movement and Sensation in Complete Paralysis for the First Time</title><link>https://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/</guid><description>A Brown University-led trial published in Nature Biomedical Engineering demonstrates simultaneous motor and sensory restoration in three people with complete spinal cord injuries using patterned electrical stimulation and machine learning.</description><pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>spinal-cord-injury</category><category>spinal-stimulation</category><category>Brown-University</category><category>Nature-Biomedical-Engineering</category><category>paralysis</category><category>sensory-restoration</category><category>motor-restoration</category></item><item><title>Brain Implants Malfunction at Night, Dutch Study Reveals Critical Gap in Round-the-Clock BCI Use</title><link>https://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/</guid><description>A UMC Utrecht study found that a brain-computer interface trained on daytime neural signals produced 245 false commands per hour when the patient slept, exposing a fundamental problem for 24/7 assistive devices.</description><pubDate>Sun, 22 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>UMC Utrecht</category><category>ECoG</category><category>ALS</category><category>sleep</category><category>signal drift</category><category>nightmode</category><category>assistive technology</category></item><item><title>FDA&apos;s One-Trial Default Lands Just as BCI Companies Approach Pivotal Studies</title><link>https://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/</guid><description>The agency&apos;s new policy ending the two-trial requirement was written for drugs, but brain implant makers watching Synchron, Neuralink, and Paradromics navigate FDA are asking whether the same logic could eventually ease their path.</description><pubDate>Sun, 22 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>FDA</category><category>regulation</category><category>pivotal trial</category><category>Synchron</category><category>Neuralink</category><category>Paradromics</category><category>Makary</category><category>Prasad</category><category>commercialization</category></item><item><title>Cambridge&apos;s Brain-Inspired Chip Material Could Cut AI Energy Use by 70%</title><link>https://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/</guid><description>A new hafnium oxide memristor from the University of Cambridge mimics biological synapses with a million-fold reduction in switching current, pointing toward more efficient neuromorphic hardware.</description><pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>neuromorphic</category><category>memristor</category><category>cambridge</category><category>energy-efficiency</category><category>hardware</category><category>research</category></item><item><title>Medicare Has No Plan for Brain-Computer Interfaces</title><link>https://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/</guid><description>A Health Affairs analysis argues that CMS needs a dedicated coverage pathway for implantable BCIs before the technology outpaces the reimbursement system that patients depend on.</description><pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>medicare</category><category>CMS</category><category>policy</category><category>reimbursement</category><category>health-affairs</category><category>patient-access</category><category>FDA</category></item><item><title>Beijing&apos;s Top BCI Startup Admits It&apos;s Three Years Behind Neuralink</title><link>https://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/</guid><description>NeuCyber Neurotech&apos;s rotating CEO concedes a significant technology gap with Musk&apos;s outfit, even as China pours state funding into catching up and expanding human trials to 50 patients.</description><pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>neucyber</category><category>neuralink</category><category>china</category><category>bci-trials</category><category>beinao</category><category>geopolitics</category></item><item><title>South Korea Launches National BCI Strategy With Seven Moonshot Missions</title><link>https://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/</guid><description>The Ministry of Science and ICT has designated brain-computer interfaces as a core future industry, setting seven mission areas from paralysis treatment to defence applications, with full-scale project funding beginning in 2027.</description><pubDate>Wed, 18 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>South Korea</category><category>K-Moonshot</category><category>policy</category><category>national strategy</category><category>Ybrain</category><category>defence</category></item><item><title>Paradromics Enlists Stanford, Mass General and Pitt to Expand BCI Applications</title><link>https://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/</guid><description>The Austin-based neurotech company launches its APEX Partnership Program with five leading research institutions, aiming to push its Connexus brain-computer interface beyond speech restoration into stroke recovery, Parkinson&apos;s and motor rehabilitation.</description><pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Paradromics</category><category>Connexus</category><category>APEX</category><category>Stanford</category><category>academic partnerships</category><category>speech restoration</category></item><item><title>BrainGate BCI Restores Typing at 22 Words Per Minute for Paralysed Patients</title><link>https://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/</guid><description>A brain-computer interface developed by Mass General Brigham and Brown University enabled two paralysed individuals to type at speeds rivalling able-bodied texting, with a word error rate of just 1.6 per cent.</description><pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>BrainGate</category><category>typing</category><category>ALS</category><category>spinal cord injury</category><category>Nature Neuroscience</category></item><item><title>Belgian Startup ReVision Implant Wins FDA Breakthrough Status for Visual BCI</title><link>https://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/</guid><description>The Leuven-based neurotech company&apos;s Occular system, which uses thousands of micro-electrodes implanted in the visual cortex to restore functional sight, has received FDA Breakthrough Device Designation.</description><pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>ReVision Implant</category><category>FDA</category><category>visual prosthesis</category><category>Occular</category><category>breakthrough device</category></item><item><title>Inside China&apos;s Sprint to Own the Brain-Computer Interface Industry</title><link>https://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/</link><guid isPermaLink="true">https://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/</guid><description>In just nine months China has issued a national BCI blueprint, overtaken the United States in BCI patent filings, funnelled hundreds of millions into startups, and has just granted the world&apos;s first commercial implant approval.</description><pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate><category>opinion</category><category>china</category><category>editorial</category><category>neuracle</category><category>stairmed</category><category>gestala</category><category>neuroxess</category><category>neuralink</category><category>industrial-policy</category><category>regulation</category></item><item><title>Alibaba Leads $72 Million Round in StairMed as Chinese Tech Giants Enter BCI</title><link>https://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/</guid><description>The invasive-BCI startup has now raised over $160 million in a year, with Alibaba and Tencent both on the cap table and multicenter clinical trials planned for later this year.</description><pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>stairmed</category><category>alibaba</category><category>tencent</category><category>china</category><category>funding</category><category>invasive-bci</category></item><item><title>China Grants First Commercial Approval for an Implantable Brain-Computer Interface</title><link>https://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/</guid><description>Neuracle Medical Technology secures NMPA clearance, making its coin-sized cortical implant the first invasive BCI anywhere in the world authorised for routine clinical sale.</description><pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>neuracle</category><category>china</category><category>nmpa</category><category>regulatory</category><category>implantable-bci</category><category>commercialisation</category></item><item><title>Gestala Raises $21 Million for Ultrasound BCI in Record Chinese Early-Stage Round</title><link>https://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/</guid><description>The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.</description><pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>Gestala</category><category>ultrasound BCI</category><category>China</category><category>funding</category><category>non-invasive</category><category>chronic pain</category><category>Tianqiao Chen</category><category>Phoenix Peng</category></item><item><title>Synaptrix Labs Unveils Atlas: Non-Invasive BCI Driving a Wheelchair with Thought Alone</title><link>https://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/</guid><description>The Mark Cuban-backed startup releases a behind-the-scenes demo of Atlas, a non-invasive brain-computer interface that translates scalp-measured neural activity into real-time wheelchair navigation using deep learning and large-scale neural datasets.</description><pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Synaptrix Labs</category><category>Atlas</category><category>non-invasive BCI</category><category>EEG</category><category>wheelchair</category><category>deep learning</category><category>Mark Cuban</category><category>assistive technology</category></item><item><title>Brain Oscillations Don&apos;t Work How We Thought They Did</title><link>https://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/</guid><description>New research upends a foundational assumption in neuroscience and BCI design: that individual frequency bands reliably map to neural activity. The discovery could reshape how we decode brain signals.</description><pubDate>Wed, 11 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>neural oscillations</category><category>brain decoding</category><category>prefrontal cortex</category><category>BCI learning</category><category>neural ensembles</category></item><item><title>Invisible Flickers Could Make Brain Monitoring Disappear Into Everyday Interfaces</title><link>https://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/</guid><description>Researchers developed a near-invisible BCI technique using texture-based visual stimuli to monitor mental workload in pilots without the distraction of traditional flickering screens.</description><pubDate>Wed, 11 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>c-VEP</category><category>passive BCI</category><category>mental workload</category><category>aviation</category><category>visual stimuli</category></item><item><title>DayOne and Cortical Labs to Build Singapore&apos;s First Biological Data Centre</title><link>https://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/</guid><description>The $20 billion data centre operator partners with the Melbourne startup that taught neurons to play Doom, planning to deploy up to 1,000 biological compute units powered by living human brain cells.</description><pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Cortical Labs</category><category>DayOne</category><category>Singapore</category><category>biological computing</category><category>wetware</category><category>NUS Medicine</category><category>data centres</category></item><item><title>Neuralink and Rivals Push Brain Chips Toward Commercial Reality</title><link>https://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/</guid><description>Multiple companies, including Elon Musk&apos;s Neuralink, are racing to bring brain-computer interface technology out of research labs and into commercial markets.</description><pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Neuralink</category><category>commercialization</category><category>brain chips</category><category>neural implants</category><category>market expansion</category></item><item><title>Self-Healing Hydrogel Makes Neuromorphic Prosthetics Resilient to Body&apos;s Chaos</title><link>https://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/</guid><description>A new iontronic reservoir built from self-healing hydrogel creates neuromorphic prostheses that can withstand the unpredictable physiological environment inside the human body.</description><pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>neuromorphic computing</category><category>hydrogel</category><category>neuroprosthetics</category><category>biocompatibility</category><category>physical reservoir computing</category></item><item><title>A Paralyzed Man in Munich Controls Computers With His Thoughts</title><link>https://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/</guid><description>Michael, a quadriplegic patient, uses 256 microelectrodes implanted in his brain to regain autonomy through thought-controlled computing. Researchers in Munich demonstrate how BCIs are moving from experimental to practical.</description><pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>invasive BCI</category><category>paralysis</category><category>microelectrodes</category><category>clinical applications</category><category>Germany</category></item><item><title>MIT&apos;s AlterEgo Demonstrates Silent Speech Interface in New Demo</title><link>https://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/</guid><description>AlterEgo, spun out from MIT Media Lab, showcases wearable device that translates internal speech into digital commands without vocalization.</description><pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>silent speech</category><category>MIT Media Lab</category><category>wearable BCI</category><category>AlterEgo</category><category>neural interface</category></item><item><title>New Database Maps Global Neuroimaging Data for Vision Decoding</title><link>https://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/</guid><description>A researcher has compiled an index of datasets used to reconstruct what people see from brain activity, potentially accelerating development of visual BCIs and neuroprosthetics.</description><pubDate>Sun, 08 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>visual perception</category><category>neuroimaging</category><category>datasets</category><category>machine learning</category><category>neural decoding</category></item><item><title>NeuroXess Breaks Ground on China&apos;s First BCI &apos;Super Factory&apos;</title><link>https://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/</guid><description>The Chinese neural interface company begins construction of the country&apos;s first dedicated manufacturing facility for implantable brain-computer interfaces in Nanchang, signaling a shift from lab to production line.</description><pubDate>Sun, 08 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>NeuroXess</category><category>China</category><category>manufacturing</category><category>Jiangxi</category><category>implantable BCI</category></item><item><title>Cognito Therapeutics Raises $105M to Bring Alzheimer&apos;s Brain Stimulation to Market</title><link>https://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/</guid><description>The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer&apos;s trial nears readout.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>cognito-therapeutics</category><category>alzheimers</category><category>neuromodulation</category><category>series-c</category><category>spectris</category></item><item><title>Evoked Potentials Could Personalize Stroke Rehab Through BCI Integration</title><link>https://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/</guid><description>A comprehensive review maps how brain signals measured during stroke recovery are converging with BCI systems and closed-loop neuromodulation to move rehabilitation beyond generic protocols toward individualized treatment.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>stroke rehabilitation</category><category>evoked potentials</category><category>closed-loop neuromodulation</category><category>clinical BCI</category><category>biomarkers</category></item><item><title>The FDA Just Quietly Redrew the Line Between Wellness Device and Medical Device</title><link>https://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/</guid><description>New guidance expands the &apos;general wellness&apos; exemption for wearables and loosens oversight of AI clinical decision tools — with major implications for every company building consumer neurotechnology.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>fda</category><category>regulation</category><category>wellness-devices</category><category>neurotech-regulation</category><category>clinical-decision-support</category><category>wearables</category></item><item><title>India Bets on Brain-Computer Interfaces with IISc Moonshot and Policy Push</title><link>https://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/</guid><description>As China and the US race ahead in neurotechnology, India&apos;s premier research institute launches an AI brain co-processor project while analysts urge strategic preparation.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>india</category><category>iisc</category><category>neurotechnology</category><category>policy</category><category>global-bci-race</category></item><item><title>Inside Neuralink&apos;s First Year: Thread Failures, Software Fixes, and Lives Changed</title><link>https://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/</guid><description>With 12+ patients implanted and mass production planned for 2026, Neuralink&apos;s clinical reality is more complicated and more human than the headlines suggest.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>neuralink</category><category>clinical-trials</category><category>brain-implant</category><category>patient-outcomes</category><category>mass-production</category></item><item><title>Salma Health Raises $80M to Build the Operating System for Brain Care</title><link>https://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/</guid><description>Backed by Mubadala and ARCH Venture Partners, the startup is merging AI diagnostics with FDA-cleared neuromodulation to consolidate fragmented psychiatric and neurological care.</description><pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>salma-health</category><category>series-a</category><category>neuromodulation</category><category>tms</category><category>saint</category><category>brain-health</category></item><item><title>Dual-Pathway Model Reconstructs Speech from Brain Signals in 20 Minutes</title><link>https://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/</guid><description>New framework resolves the historic trade-off between acoustic richness and linguistic clarity in neural speech decoding, achieving 4.0/5.0 intelligibility with minimal training data.</description><pubDate>Fri, 06 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>speech BCI</category><category>ECoG</category><category>neural decoding</category><category>speech synthesis</category><category>machine learning</category></item><item><title>Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant</title><link>https://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/</guid><description>Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.</description><pubDate>Fri, 06 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>Science Corp</category><category>funding</category><category>Series C</category><category>PRIMA</category><category>vision restoration</category><category>retinal implant</category><category>Khosla Ventures</category><category>Lightspeed</category></item><item><title>Tether Backs Eight Sleep at $1.5B Valuation, Deepening Its Health-Tech Thesis</title><link>https://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/</guid><description>The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.</description><pubDate>Fri, 06 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Tether</category><category>Eight Sleep</category><category>Blackrock Neurotech</category><category>health tech</category><category>investment</category><category>QVAC</category></item><item><title>Blind Korean YouTuber Volunteers for Neuralink&apos;s Blindsight Trial</title><link>https://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/</guid><description>Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink&apos;s Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Neuralink</category><category>Blindsight</category><category>clinical trial</category><category>vision restoration</category><category>brain implant</category><category>South Korea</category></item><item><title>China Designates BCIs a Strategic Industry with 2027 Breakthrough Targets</title><link>https://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/</link><guid isPermaLink="true">https://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/</guid><description>Seven Chinese government bodies have released guidelines establishing a roadmap for brain-computer interface development, with BCI procedures now receiving medical insurance reimbursement in parts of the country.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>policy</category><category>China</category><category>BCI policy</category><category>regulation</category><category>medical insurance</category><category>global market</category><category>investment</category></item><item><title>Chinese Team Decodes Semantic Meaning From Brain Waves in Aphasia Patients</title><link>https://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/</guid><description>Researchers developed TFSANet, a deep learning model that decodes language comprehension from EEG signals, achieving 60.73% accuracy in aphasia patients using Chinese linguistic stimuli.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>semantic decoding</category><category>aphasia</category><category>EEG</category><category>speech BCI</category><category>language processing</category></item><item><title>Gobi Partners Backs Cortical Labs as Biological Computing Hub Expands in Malaysia</title><link>https://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/</link><guid isPermaLink="true">https://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/</guid><description>Malaysia-based Gobi Partners has invested in Cortical Labs through its Dana Impak Ventures fund, joining Horizon Ventures and Synchron founder Tom Oxley in backing the biological computing startup.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>market</category><category>Cortical Labs</category><category>Gobi Partners</category><category>biological computing</category><category>Malaysia</category><category>investment</category><category>Horizon Ventures</category><category>Synchron</category></item><item><title>Science Corp and Neurosoft Partner to Cut BCI Clinical Trial Costs</title><link>https://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/</guid><description>A new partnership between Science Corp and Neurosoft AI aims to dramatically reduce the cost and timeline of brain-computer interface clinical trials through shared infrastructure and software tools.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Science Corp</category><category>Neurosoft</category><category>clinical trials</category><category>partnerships</category><category>BCI infrastructure</category></item><item><title>Seven-Tesla Brain Scans Reveal Optimal Target for Gesture-Decoding Implants</title><link>https://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/</guid><description>New fMRI research identifies precise cortical locations for implantable BCI electrodes, finding that surface recordings from gyral regions may suffice for gesture decoding without penetrating sulcal depths.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>implantable BCI</category><category>motor cortex mapping</category><category>gesture decoding</category><category>electrode placement</category><category>fMRI</category></item><item><title>Software Testing Technique Exposes Safety Flaws in ML Neurostimulation</title><link>https://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/</guid><description>Researchers adapted automated fuzzing from software security to stress-test machine learning models that control neural implants, revealing widespread violations of biophysical safety limits in retinal and cortical devices.</description><pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>machine learning</category><category>neural stimulation</category><category>safety</category><category>visual prostheses</category><category>regulatory</category></item><item><title>Indian Child Regains Hearing Through Brainstem Neural Implant</title><link>https://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/</guid><description>AIIMS Delhi performs first auditory brainstem implant in India, demonstrating neural bypass technology&apos;s potential for patients unsuitable for conventional cochlear devices.</description><pubDate>Wed, 04 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>auditory brainstem implant</category><category>AIIMS</category><category>neural bypass</category><category>hearing restoration</category><category>India</category></item><item><title>Chinese Startup Gestala Enters Ultrasound BCI Race for Pain Treatment</title><link>https://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/</guid><description>A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.</description><pubDate>Tue, 03 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>ultrasound</category><category>non-invasive BCI</category><category>China</category><category>chronic pain</category><category>Gestala</category></item><item><title>Wireless Retinal Implant Restores Vision in 80% of Trial Participants</title><link>https://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/</guid><description>A major clinical trial shows wireless neural implants restored meaningful central vision to those blinded by macular degeneration, with participants reading letters and words.</description><pubDate>Tue, 03 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>retinal implants</category><category>visual prosthetics</category><category>clinical trials</category><category>macular degeneration</category><category>sensory restoration</category></item><item><title>Brain Stimulation Improves BCI Control Through Two Distinct Neural Pathways</title><link>https://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/</guid><description>New research reveals how targeting different brain regions with theta burst stimulation enhances motor imagery performance through separate mechanisms, offering potential solutions for stroke patients struggling with BCI control.</description><pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>transcranial magnetic stimulation</category><category>motor imagery</category><category>stroke rehabilitation</category><category>brain stimulation</category><category>functional connectivity</category></item><item><title>Living Neurons Learn Doom in a Week, Signaling New Era</title><link>https://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/</guid><description>Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.</description><pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>organoid intelligence</category><category>biological computing</category><category>Cortical Labs</category><category>in vitro neurons</category><category>synthetic biology</category></item><item><title>NeuroXess Completes Human Trials as China Accelerates BCI Race</title><link>https://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/</guid><description>Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.</description><pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>NeuroXess</category><category>China</category><category>Neuralink</category><category>human trials</category><category>international competition</category></item><item><title>Nicolelis Study in China Shows Brain Reorganization Restores Movement</title><link>https://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/</link><guid isPermaLink="true">https://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/</guid><description>Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.</description><pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate><category>news</category><category>Miguel Nicolelis</category><category>paralysis</category><category>neural plasticity</category><category>China</category><category>motor recovery</category></item><item><title>Personalized Brain Decoders Track Chronic Pain Without Patient Input</title><link>https://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/</link><guid isPermaLink="true">https://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/</guid><description>Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.</description><pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate><category>research</category><category>pain decoding</category><category>fMRI</category><category>chronic pain</category><category>personalized medicine</category><category>neuroimaging</category></item><item><title>Neuralink Clears Major Hurdle: FDA Approves Expanded Clinical Trial Enrollment</title><link>https://insidebci.com/news/neuralink-fda-expanded-trial/</link><guid isPermaLink="true">https://insidebci.com/news/neuralink-fda-expanded-trial/</guid><description>FDA grants approval for Neuralink to enroll significantly more participants in its brain-computer interface clinical trials, marking a major step toward commercialization.</description><pubDate>Sat, 28 Feb 2026 00:00:00 GMT</pubDate><category>news</category><category>neuralink</category><category>FDA</category><category>clinical-trials</category><category>brain-computer-interface</category></item><item><title>EU Proposes Landmark &apos;Neuro-Rights&apos; Framework: First Major Regulatory Push for Brain Data Privacy</title><link>https://insidebci.com/policy/eu-neuro-rights-framework/</link><guid isPermaLink="true">https://insidebci.com/policy/eu-neuro-rights-framework/</guid><description>European Commission outlines sweeping rules protecting cognitive liberty and neural data, setting global standard for brain-computer interface regulation.</description><pubDate>Sun, 22 Feb 2026 00:00:00 GMT</pubDate><category>policy</category><category>EU-regulation</category><category>neuro-rights</category><category>privacy</category><category>policy</category></item></channel></rss>